Laboratory_NN Diagnosis_NN of_IN Lower_NP Respiratory_NP Tract_NP Infections_NNS :_: Controversy_NN and_CC Conundrums_NNS null_JJ Even_RB though_IN acute_JJ bronchitis_NN is_VBZ clearly_RB one_CD of_IN the_DT most_RBS common_JJ diagnoses_NNS made_VBN in_IN adult_JJ clinical_JJ practice_NN ,_, a_DT precise_JJ definition_NN does_VBZ not_RB exist_VB ._SENT A_DT cough_NN that_WDT lasts_VBZ 1_CD to_TO 3_CD weeks_NNS ,_, with_IN or_CC without_IN sputum_NN production_NN ,_, and_CC that_WDT is_VBZ associated_VBN with_IN upper_JJ respiratory_JJ tract_NN and_CC constitutional_JJ symptoms_NNS is_VBZ the_DT typical_JJ presentation_NN ._SENT Symptoms_NNS result_VBP from_IN inflammation_NN and_CC hyperresponsiveness_NN of_IN the_DT bronchial_JJ tree_NN ._SENT Table_NN lists_VBZ the_DT most_RBS common_JJ pathogens_NNS implicated_VBN in_IN acute_JJ bronchitis_NN ._SENT Viruses_NNS ,_, especially_RB influenza_NN virus_NN ,_, cause_VB the_DT vast_JJ majority_NN of_IN cases_NNS in_IN studies_NNS that_WDT establish_VB an_DT etiology_NN ._SENT Respiratory_JJ syncytial_JJ virus_NN can_MD also_RB cause_VB symptomatic_JJ lower_JJR respiratory_JJ tract_NN disease_NN ,_, especially_RB in_IN elderly_JJ patients_NNS ._SENT Nonviral_JJ agents_NNS that_WDT have_VBP been_VBN implicated_VBN include_VBP Mycoplasma_NP pneumoniae_NNS ,_, Chlamydia_NP pneumoniae_NP ,_, Bordetella_NP pertussis_NN ,_, and_CC Bordetella_NP parapertussis_NN ._SENT The_DT latter_JJ pathogens_NNS are_VBP most_RBS frequently_RB seasonal_JJ and_CC occur_VB in_IN epidemics_NNS ._SENT There_EX are_VBP no_DT data_NNS to_TO suggest_VB that_IN Streptococcus_NP pneumoniae_NNS ,_, Haemophilus_NP influenzae_NP ,_, and_CC Moraxella_NP catarrhalis_NNS are_VBP important_JJ pathogens_NNS in_IN uncomplicated_JJ bronchitis_NN ._SENT Diagnosis_NN is_VBZ usually_RB made_VBN clinically_RB ._SENT Purulent_JJ sputum_NN is_VBZ not_RB predictive_JJ of_IN viral_JJ infections_NNS versus_IN bacterial_JJ infections_NNS ._SENT Microscopic_JJ examination_NN of_IN sputum_NN and_CC culture_NN are_VBP not_RB helpful_JJ in_IN distinguishing_VBG upper_JJ airway_NN colonization_NN from_IN lower_JJR airway_NN infection_NN ._SENT Meta-analyses_NNS of_IN numerous_JJ prospective_JJ studies_NNS have_VBP not_RB demonstrated_VBN the_DT value_NN of_IN microbiological_JJ studies_NNS in_IN the_DT management_NN of_IN patients_NNS with_IN uncomplicated_JJ acute_JJ bronchitis_NN ._SENT Rapid_JJ tests_NNS for_IN influenza_NN virus_NN are_VBP limited_VBN by_IN sensitivities_NNS equivalent_JJ to_TO that_DT of_IN clinical_JJ judgment_NN when_WRB influenza_NN is_VBZ circulating_VBG in_IN a_DT community_NN (_( 70_CD and_CC 65_CD to_TO 80_CD %_NN ,_, respectively_RB )_) ._SENT Perhaps_RB the_DT one_CD exception_NN to_TO the_DT previous_JJ statement_NN is_VBZ the_DT patient_NN with_IN possible_JJ pertussis_NN ._SENT Diagnostic_JJ tests_NNS should_MD be_VB performed_VBN for_IN the_DT patient_NN with_IN chronic_JJ cough_NN in_IN the_DT setting_NN of_IN appropriate_JJ epidemiology_NN ,_, since_IN pertussis_NN is_VBZ indistinguishable_JJ clinically_RB from_IN other_JJ causes_NNS of_IN bronchitis_NN and_CC adults_NNS may_MD be_VB vectors_NNS of_IN infection_NN in_IN nonimmunized_JJ infants_NNS or_CC incompletely_RB immunized_VBN children_NNS ._SENT Table_NN lists_VBZ the_DT available_JJ diagnostic_JJ tests_NNS ._SENT Acute_JJ exacerbation_NN of_IN chronic_JJ bronchitis_NN in_IN patients_NNS with_IN underlying_VBG lung_NN disease_NN is_VBZ usually_RB distinguished_VBN from_IN the_DT uncomplicated_JJ syndrome_NN discussed_VBN above_IN ._SENT Although_IN Streptococcus_NP pneumoniae_NP and_CC Haemophilus_NP influenzae_NP contribute_VBP more_RBR frequently_RB to_TO acute_JJ symptoms_NNS in_IN patients_NNS with_IN chronic_JJ obstructive_JJ pulmonary_JJ disease_NN ,_, viral_JJ pathogens_NNS are_VBP likely_RB responsible_JJ for_IN a_DT significant_JJ number_NN of_IN episodes_NNS (_( 30_CD to_TO 40_CD %_NN )_) ._SENT Gram-stained_JJ smears_NNS and_CC culture_NN are_VBP of_IN limited_JJ value_NN because_IN as_RB many_JJ as_IN 25_CD %_NN of_IN patients_NNS with_IN chronic_JJ obstructive_JJ pulmonary_JJ disease_NN have_VBP upper_JJ airway_NN colonization_NN with_IN bacterial_JJ pathogens_NNS in_IN the_DT absence_NN of_IN symptoms_NNS ._SENT Management_NN of_IN these_DT patients_NNS remains_VBZ controversial_JJ ._SENT TABLE_NN 1_CD |_SYM Most_RBS common_JJ pathogens_NNS implicated_VBN in_IN lower_JJR respiratory_JJ tract_NN syndromes_NNS and_CC their_PP$ relative_JJ contributions_NNS TABLE_NP 2_CD |_SYM Diagnostic_JJ studies_NNS for_IN specific_JJ agents_NNS of_IN lower_JJR respiratory_JJ tract_NN infections_NNS ACQUIRED_JJ PNEUMONIA_NP :_: CAP_NN is_VBZ usually_RB characterized_VBN by_IN fever_NN ,_, chills_NNS ,_, dyspnea_NN ,_, cough_NN ,_, and_CC pleuritic_JJ chest_NN pain_NN in_IN association_NN with_IN physical_JJ findings_NNS suggestive_JJ of_IN consolidation_NN in_IN persons_NNS who_WP become_VBP ill_RB outside_JJ of_IN a_DT hospital_NN or_CC chronic-care_NN facility_NN ._SENT Table_NN l_NN lists_VBZ some_DT common_JJ organisms_NNS that_WDT are_VBP associated_VBN with_IN CAP_NP ._SENT Streptococcus_NN pneumoniae_NNS is_VBZ still_RB considered_VBN the_DT major_JJ cause_NN of_IN CAP_NP ._SENT The_DT relative_JJ contributions_NNS of_IN agents_NNS such_JJ as_IN Mycoplasma_NP pneumoniae_NP and_CC Chlamydia_NP pneumoniae_NNS depend_VBP upon_IN the_DT published_VBN series_NN ,_, whether_IN there_EX was_VBD a_DT community_NN outbreak_NN at_IN the_DT time_NN of_IN the_DT study_NN ,_, and_CC the_DT diagnostic_JJ method_NN used_VBD ._SENT The_DT practice_NN guidelines_NNS of_IN both_CC the_DT American_NP Thoracic_NP Society_NP (_( ATS_NP )_) and_CC the_DT Infectious_NP Diseases_NPS Society_NP of_IN America_NP (_( IDSA_NP )_) emphasize_VBP using_VBG the_DT history_NN and_CC physical_JJ examination_NN to_TO aid_VB in_IN the_DT selection_NN of_IN nonmicrobiological_JJ diagnostic_JJ tests_NNS for_IN assessment_NN of_IN the_DT severity_NN of_IN illness_NN and_CC as_IN a_DT guide_NN to_TO empirical_JJ antibiotic_JJ choices_NNS ._SENT The_DT history_NN may_MD also_RB provide_VB certain_JJ epidemiological_JJ clues_NNS that_WDT may_MD be_VB important_JJ when_WRB considering_VBG a_DT particular_JJ etiology_NN ._SENT For_IN example_NN ,_, hantavirus_NN pulmonary_JJ syndrome_NN should_MD be_VB considered_VBN in_IN the_DT otherwise_RB healthy_JJ patient_NN who_WP presents_VBZ with_IN a_DT prodromal_JJ illness_NN that_WDT rapidly_RB progresses_VBZ to_TO adult_JJ respiratory_JJ distress_NN syndrome_NN following_VBG activities_NNS in_IN an_DT area_NN of_IN endemicity_NN that_WDT increase_VBP the_DT risk_NN of_IN exposure_NN to_TO rodents_NNS ._SENT Both_DT ATS_NP and_CC IDSA_NP recommend_VBP chest_NN radiography_NN to_TO distinguish_VB pneumonia_NN ,_, which_WDT requires_VBZ antibiotics_NNS ,_, from_IN acute_JJ bronchitis_NN ,_, which_WDT is_VBZ most_RBS commonly_RB viral_JJ in_IN etiology_NN ._SENT The_DT chest_NN radiograph_NN lacks_VBZ specificity_NN in_IN establishing_VBG a_DT microbial_JJ cause_NN of_IN CAP_NP ,_, but_CC it_PP may_MD provide_VB clues_NNS to_TO the_DT diagnosis_NN of_IN perhaps_RB unsuspected_JJ illnesses_NNS that_WDT may_MD be_VB mistaken_VBN for_IN CAP_NN such_JJ as_IN tuberculosis_NN and_CC Pneumocystis_NP carinii_NP infection_NN ._SENT Detection_NN of_IN an_DT etiologic_JJ agent_NN causing_VBG infection_NN such_PDT that_DT directed_VBN therapy_NN is_VBZ permitted_VBN is_VBZ the_DT role_NN of_IN microbiological_JJ tests_NNS ._SENT Unfortunately_RB ,_, the_DT ideal_JJ test_NN for_IN most_JJS pathogens_NNS does_VBZ not_RB yet_RB exist_VB ._SENT Methods_NNS include_VBP sputum_NN Gram_NP stain_NN and_CC culture_NN ,_, blood_NN cultures_NNS ,_, serologic_JJ studies_NNS ,_, antigen_NN detection_NN tests_NNS ,_, and_CC nucleic_JJ acid_JJ amplification_NN methods_NNS ._SENT Table_NN lists_VBZ the_DT methods_NNS available_JJ for_IN the_DT detection_NN of_IN most_JJS common_JJ pathogens_NNS associated_VBN with_IN CAP_NP ._SENT Among_IN these_DT methods_NNS ,_, perhaps_RB the_DT most_RBS controversial_JJ are_VBP the_DT sputum_NN Gram_NP stain_NN and_CC culture_NN ._SENT The_DT IDSA_NP guidelines_NNS recommend_VBP these_DT for_IN patients_NNS with_IN CAP_NP who_WP require_VBP hospitalization_NN ,_, whereas_IN the_DT ATS_JJ guidelines_NNS do_VBP not_RB ._SENT While_IN often_RB regarded_VBN as_IN a_DT simple_JJ test_NN ,_, proper_JJ collection_NN of_IN the_DT sputum_NN sample_NN ,_, rapid_JJ transport_NN to_TO the_DT laboratory_NN ,_, adequate_JJ sampling_NN of_IN the_DT purulent_JJ component_NN of_IN the_DT sample_NN ,_, preparation_NN of_IN the_DT stain_NN ,_, and_CC interpretation_NN are_VBP all_RB required_VBN ._SENT The_DT values_NNS of_IN the_DT sputum_NN stain_NN and_CC culture_NN results_NNS are_VBP also_RB dependent_JJ upon_IN the_DT pretest_JJ probability_NN that_IN the_DT patient_NN has_VBZ bacterial_JJ pneumonia_NN and_CC upon_IN whether_IN the_DT patient_NN has_VBZ received_VBN antibiotics_NNS ._SENT Add_VB to_TO this_DT a_DT recent_JJ study_NN which_WDT demonstrated_VBD the_DT intralaboratory_JJ sampling_NN variability_NN of_IN expectorated_VBN sputum_NN in_IN five_CD centers_NNS and_CC it_PP is_VBZ clear_JJ why_WRB the_DT value_NN of_IN the_DT Gram_NP stain_NN has_VBZ been_VBN challenged_VBN ._SENT However_RB ,_, proponents_NNS argue_VBP that_IN when_WRB the_DT caveats_NNS mentioned_VBN above_IN are_VBP fulfilled_VBN ,_, namely_RB ,_, adequate_JJ sputum_NN collection_NN from_IN a_DT patient_NN with_IN productive_JJ purulent_JJ sputum_NN who_WP has_VBZ not_RB received_VBN antibiotics_NNS ,_, the_DT demonstration_NN of_IN a_DT predominant_JJ morphotype_NN may_MD be_VB useful_JJ in_IN guiding_VBG pathogen-oriented_JJ antimicrobial_JJ therapy_NN ._SENT In_IN a_DT recent_JJ study_NN by_IN Rozon_NP et_FW al._FW ,_, the_DT sensitivity_NN and_CC specificity_NN of_IN a_DT Gram_NP stain_NN from_IN a_DT good-quality_NN specimen_NN for_IN the_DT diagnosis_NN of_IN pneumococcal_JJ pneumonia_NN and_CC Haemophilus_NP influenzae_NP pneumonia_NN were_VBD 57_CD and_CC 82_CD %_NN ,_, respectively_RB ,_, and_CC 97_CD and_CC 99_CD %_NN ,_, respectively_RB ._SENT Moreover_RB ,_, in_IN those_DT patient_JJ samples_NNS in_IN whom_WP a_DT predominant_JJ morphotype_NN was_VBD seen_VBN ,_, 95_CD %_NN of_IN patients_NNS received_VBD monotherapy_NN as_IN opposed_VBN to_TO combination_NN therapy_NN ,_, leading_VBG to_TO potential_JJ cost_NN savings_NNS and_CC less_JJR antimicrobial_JJ agent-related_JJ adverse_JJ events_NNS ._SENT If_IN it_PP is_VBZ decided_VBN to_TO send_VB a_DT sample_NN to_TO the_DT laboratory_NN ,_, patients_NNS should_MD be_VB given_VBN proper_JJ instructions_NNS ._SENT Food_NP should_MD not_RB have_VB been_VBN ingested_VBN for_IN 1_CD to_TO 2_CD h_NN prior_JJ to_TO expectoration_NN ._SENT The_DT mouth_NN should_MD be_VB rinsed_VBN with_IN saline_NN or_CC water_NN ,_, and_CC the_DT patient_NN should_MD be_VB encouraged_VBN to_TO breathe_VB and_CC cough_VB deeply_RB and_CC expectorate_VB immediately_RB into_IN a_DT sterile_JJ container_NN ._SENT Ideally_RB ,_, the_DT sample_NN is_VBZ then_RB transported_VBN immediately_RB to_TO the_DT laboratory_NN ,_, where_WRB it_PP is_VBZ stained_VBN and_CC plated_VBN as_IN soon_RB as_RB possible_JJ upon_IN receipt_NN ._SENT At_IN the_DT University_NP of_IN Utah_NP ,_, attempts_VBZ to_TO standardize_VB collection_NN as_IN part_NN of_IN an_DT institutionwide_JJ focus_NN on_IN appropriate_JJ management_NN of_IN respiratory_JJ tract_NN infections_NNS failed_VBN because_IN the_DT burden_NN fell_VBD to_TO already_RB overworked_VBN nurses_NNS or_CC respiratory_JJ therapists_NNS who_WP simply_RB could_MD not_RB perform_VB these_DT time-consuming_JJ steps_NNS (_( personal_JJ communication_NN )_) ._SENT Once_RB the_DT specimen_NN reaches_VBZ the_DT microbiology_NN laboratory_NN ,_, it_PP has_VBZ been_VBN established_VBN that_IN a_DT microscopic_JJ screen_NN to_TO exclude_VB those_DT samples_NNS that_WDT represent_VBP upper_JJ airway_NN contamination_NN is_VBZ beneficial_JJ and_CC cost-effective_JJ ._SENT The_DT specimen_NN is_VBZ viewed_VBN under_IN low_JJ power_NN (_( x10_JJ objective_NN )_) ,_, and_CC the_DT numbers_NNS of_IN epithelial_JJ cells_NNS and/or_CC polymorphonuclear_JJ leukocytes_NNS (_( PMNs_NP )_) present_VBP establish_VB the_DT degree_NN of_IN contamination_NN ._SENT The_DT presence_NN of_IN many_JJ epithelial_JJ cells_NNS and_CC few_JJ to_TO no_DT PMNs_NP is_VBZ suggestive_JJ of_IN a_DT poorly_RB collected_VBN sample_NN and_CC the_DT sample_NN should_MD not_RB be_VB planted_VBN ._SENT Multiple_JJ specific_JJ criteria_NNS incorporating_VBG PMNs_NP ,_, epithelial_JJ cells_NNS ,_, mucus_NN stranding_VBG ,_, and_CC the_DT presence_NN of_IN bronchial_JJ epithelial_JJ cells_NNS have_VBP been_VBN published_VBN ;_: but_CC the_DT superiority_NN of_IN one_CD method_NN over_IN the_DT others_NNS has_VBZ not_RB been_VBN established_VBN ._SENT If_IN the_DT sample_NN is_VBZ inadequate_JJ ,_, a_DT new_JJ one_CD can_MD be_VB requested_VBN ._SENT In_IN good-quality_NN screened_VBD samples_NNS ,_, the_DT presence_NN of_IN a_DT predominant_JJ bacterial_JJ morphotype_NN should_MD also_RB be_VB reported_VBN ._SENT Screening_NN should_MD not_RB be_VB applied_VBN to_TO samples_NNS obtained_VBN from_IN patients_NNS with_IN possible_JJ Legionella_NP or_CC Mycobacterium_NP tuberculosis_NN infection_NN ._SENT Routine_JJ sputum_NN specimens_NNS are_VBP typically_RB planted_VBN on_IN blood_NN agar_NN ,_, chocolate_NN agar_NN ,_, and_CC MacConkey_NP agar_NN ._SENT Although_IN patients_NNS with_IN Legionella_NP pneumonia_NN rarely_RB produce_VB purulent_JJ sputum_NN ,_, a_DT Gram_NP stain_NN that_WDT demonstrates_VBZ abundant_JJ PMNs_NNS with_IN scant_JJ respiratory_JJ flora_NN (_( in_IN a_DT patient_NN not_RB on_IN antibiotics_NNS )_) is_VBZ cause_NN for_IN suspicion_NN for_IN this_DT pathogen_NN ,_, and_CC the_DT use_NN of_IN a_DT medium_NN selective_JJ for_IN Legionella_NP should_MD be_VB considered_VBN after_IN consultation_NN with_IN the_DT physician_NN ._SENT While_IN the_DT diagnostic_JJ yield_NN from_IN blood_NN samples_NNS from_IN patients_NNS with_IN CAP_NP is_VBZ low_JJ (_( 5_CD to_TO 16_CD %_NN )_) ,_, both_CC ATS_NP and_CC IDSA_NP recommend_VBP obtaining_VBG them_PP from_IN hospitalized_VBN patients_NNS before_IN antibiotic_JJ therapy_NN is_VBZ administered_VBN ._SENT The_DT benefits_NNS include_VBP definitive_JJ identification_NN of_IN the_DT etiologic_JJ agent_NN and_CC an_DT estimate_NN of_IN a_DT prognosis_NN ,_, which_WDT is_VBZ helpful_JJ for_IN patient_JJ management_NN ._SENT Up_RB to_TO 40_CD %_NN of_IN patients_NNS admitted_VBN with_IN CAP_NP will_MD have_VB an_DT accompanying_JJ pleural_JJ effusion_NN ._SENT The_DT decision_NN to_TO perform_VB a_DT thoracentesis_NN is_VBZ a_DT clinical_JJ one_CD ,_, but_CC a_DT Gram_NP stain_NN and_CC culture_NN of_IN the_DT fluid_NN with_IN the_DT media_NNS discussed_VBN above_RB should_MD be_VB performed_VBN ._SENT Infected_JJ fluids_NNS are_VBP managed_VBN aggressively_RB with_IN chest_NN tube_NN drainage_NN ,_, whereas_IN small_JJ parapneumonic_JJ effusions_NNS typically_RB resolve_VB on_IN their_PP$ own_JJ ._SENT Antigen_NN detection_NN tests_NNS have_VBP a_DT role_NN in_IN the_DT establishment_NN of_IN viral_JJ etiologies_NNS such_JJ as_IN respiratory_JJ syncytial_JJ virus_NN and_CC influenza_NN virus_NN ._SENT Direct_JJ fluorescent-antibody_NN tests_NNS are_VBP more_RBR sensitive_JJ than_IN point-of-care_JJ rapid_JJ tests_NNS ._SENT The_DT specimen_NN of_IN choice_NN is_VBZ a_DT nasal_JJ aspirate_NN or_CC wash_NN or_CC a_DT nasopharyngeal_JJ swab_NN ._SENT Throat_NN swab_NN specimens_NNS are_VBP less_RBR useful_JJ ._SENT Urinary_JJ antigen_NN tests_NNS should_MD be_VB performed_VBN for_IN patients_NNS suspected_VBN of_IN having_VBG Legionella_NP pneumophila_NP infection_NN ,_, particularly_RB in_IN geographic_JJ settings_NNS where_WRB serogroup_NN 1_CD predominates_VBZ ._SENT The_DT sensitivity_NN ranges_VBZ from_IN 70_CD to_TO 90_CD %_NN ,_, and_CC the_DT specificity_NN is_VBZ >99_JJ %_NN ._SENT Recently_RB ,_, a_DT new_JJ method_NN for_IN detection_NN of_IN Streptococcus_NP pneumoniae_NNS antigen_NN in_IN urine_NN ,_, an_DT immunochromatographic_JJ assay_NN (_( NOW_NP S._NP pneumoniae_NNS urinary_JJ antigen_NN test_NN ;_: Binax_NP ,_, Inc._NP ,_, Portland_NP ,_, Maine_NP )_) ,_, has_VBZ become_VBN available_JJ ._SENT A_DT large_JJ study_NN of_IN 420_CD adults_NNS with_IN CAP_NP and_CC 169_CD control_NN patients_NNS demonstrated_VBD that_IN the_DT test_NN has_VBZ a_DT high_JJ degree_NN of_IN specificity_NN and_CC a_DT sensitivity_NN of_IN 80_CD %_NN when_WRB positivity_NN by_IN blood_NN culture_NN was_VBD used_VBN for_IN comparison_NN ._SENT Serologic_JJ studies_NNS are_VBP usually_RB reserved_VBN for_IN the_DT atypical_JJ pathogens_NNS including_VBG Mycoplasma_NP pneumoniae_NNS ,_, Chlamydia_NP pneumoniae_NNS ,_, and_CC Legionella_NP pneumophila_NP ,_, among_IN others_NNS ._SENT The_DT relative_JJ contributions_NNS of_IN these_DT pathogens_NNS to_TO cases_NNS of_IN CAP_NP vary_VBP depending_VBG upon_IN the_DT population_NN studied_VBD and_CC the_DT diagnostic_JJ methods_NNS used_VBD ._SENT Diagnosis_NN of_IN infections_NNS caused_VBN by_IN these_DT pathogens_NNS is_VBZ particularly_RB problematic_JJ because_IN the_DT clinical_JJ presentations_NNS may_MD be_VB confused_VBN with_IN a_DT variety_NN of_IN other_JJ infectious_JJ agents_NNS ,_, and_CC culture_NN ,_, while_IN possible_JJ ,_, is_VBZ either_RB insensitive_JJ or_CC slow_JJ and_CC requires_VBZ specialized_JJ culture_NN techniques_NNS ._SENT Unfortunately_RB ,_, the_DT most_RBS reliable_JJ serologic_JJ evidence_NN implicating_VBG infection_NN with_IN one_CD of_IN the_DT organisms_NNS mentioned_VBN above_RB requires_VBZ a_DT fourfold_JJ increase_NN in_IN immunoglobulin_NN G_NP antibody_NN titers_NNS between_IN acute-_NN and_CC convalescent-phase_NN serum_NN samples_NNS ,_, which_WDT confirms_VBZ but_CC which_WDT does_VBZ not_RB establish_VB the_DT diagnosis_NN early_RB enough_RB to_TO be_VB useful_JJ in_IN routine_JJ patient_JJ management_NN ._SENT Given_VBN the_DT lack_NN of_IN rapid_JJ or_CC reliable_JJ methods_NNS for_IN the_DT detection_NN of_IN these_DT agents_NNS ,_, the_DT practice_NN guidelines_NNS of_IN both_DT ATS_NP and_CC IDSA_NP have_VBP incorporated_VBN empirical_JJ therapeutic_JJ regimens_NNS that_WDT are_VBP routinely_RB used_VBN for_IN the_DT treatment_NN of_IN infections_NNS caused_VBN by_IN these_DT organisms_NNS ._SENT Nucleic_JJ acid_JJ amplification_NN tests_NNS have_VBP been_VBN developed_VBN by_IN many_JJ laboratories_NNS to_TO more_RBR rapidly_RB and_CC accurately_RB detect_VB those_DT pathogens_NNS that_WDT are_VBP difficult_JJ to_TO culture_NN ._SENT A_DT commercial_JJ multiplex_JJ PCR_NP assay_NN for_IN the_DT detection_NN of_IN respiratory_JJ virus_NN infections_NNS is_VBZ available_JJ as_IN a_DT test_NN for_IN research_NN use_NN only_RB (_( application_NN for_IN approval_NN has_VBZ been_VBN submitted_VBN to_TO the_DT U.S._NP Food_NP and_CC Drug_NP Administration_NP )_) ._SENT It_PP has_VBZ excellent_JJ sensitivity_NN and_CC specificity_NN but_CC is_VBZ costly_JJ and_CC time-consuming_JJ ._SENT Likewise_RB ,_, PCR_NP detection_NN of_IN Bordetella_NP pertussis_NN and_CC Bordetella_NP parapertussis_NN has_VBZ been_VBN shown_VBN to_TO be_VB more_RBR rapid_JJ and_CC at_IN least_JJS equivalent_NN to_TO culture_NN ,_, provided_VBD that_IN calcium_NN alginate_NN swabs_NNS are_VBP not_RB used_VBN for_IN specimen_NN collection_NN ._SENT Two_CD U.S._NP Food_NP and_CC Drug_NP Administration-approved_NP commercial_JJ nucleic_JJ acid_JJ amplification_NN tests_NNS for_IN direct_JJ detection_NN of_IN Mycobacterium_NN tuberculosis_NN from_IN respiratory_JJ samples_NNS are_VBP available_JJ ,_, the_DT AMTDT_NP (_( Gen-Probe_NP Inc._NP ,_, San_NP Diego_NP ,_, Calif._NP )_) and_CC the_DT Amplicor_NP and_CC COBAS_NP (_( Roche_NP Molecular_NP ,_, Branchburg_NP ,_, N.J._NP )_) tests_NNS ._SENT Optimal_JJ protocols_NNS for_IN detection_NN of_IN other_JJ pathogens_NNS have_VBP yet_RB to_TO be_VB established_VBN ._SENT The_DT following_VBG parameters_NNS should_MD be_VB established_VBN before_IN a_DT nucleic_JJ acid_NN test_NN is_VBZ incorporated_VBN into_IN routine_JJ clinical_JJ use_NN for_IN a_DT particular_JJ pathogen_NN :_: optimum_JJ specimen_NN type_NN ,_, internal_JJ inhibition_NN control_NN ,_, analytical_JJ and_CC clinical_JJ sensitivity_NN and_CC specificity_NN ,_, and_CC reproducibility_NN (_( CAP_NN guidelines_NNS )_) Pneumonia_NP is_VBZ the_DT most_RBS frequent_JJ nosocomial_JJ infection_NN (_( 30_CD to_TO 33_CD %_NN of_IN cases_NNS )_) among_IN combined_JJ medical-surgical_JJ intensive_JJ care_NN units_NNS participating_VBG in_IN the_DT National_NP Nosocomial_NP Infections_NP Surveillance_NP System_NP ._SENT In_IN the_DT intensive_JJ care_NN unit_NN setting_NN ,_, 83_CD %_NN of_IN cases_NNS of_IN pneumonia_NN are_VBP associated_VBN with_IN mechanical_JJ ventilation_NN ._SENT Staphylococcus_NN aureus_NN is_VBZ the_DT most_RBS frequently_RB reported_VBN isolate_NN at_IN 17_CD %_NN ._SENT Fifty-nine_NN percent_NN of_IN reported_JJ isolates_NNS are_VBP aerobic_JJ gram-negative_JJ species_NNS ,_, the_DT most_RBS common_JJ of_IN which_WDT is_VBZ Pseudomonas_NP aeruginosa_NP (_( 15.6_CD %_NN )_) ,_, followed_VBN by_IN Enterobacter_NP species_NNS (_( 10.9_CD %_NN )_) and_CC Klebsiella_NP pneumoniae_NNS (_( 7.0_CD %_NN )_) ._SENT Frequently_RB ,_, infection_NN is_VBZ polymicrobial_JJ ._SENT The_DT diagnosis_NN of_IN pneumonia_NN in_IN the_DT hospitalized_VBN patient_NN is_VBZ even_RB more_RBR challenging_JJ than_IN the_DT diagnosis_NN of_IN CAP_NP ._SENT When_WRB fever_NN ,_, leukocytosis_NN ,_, and_CC purulent_JJ tracheal_JJ secretions_NNS develop_VBP in_IN association_NN with_IN an_DT abnormal_JJ chest_NN radiograph_NN ,_, the_DT likelihood_NN of_IN pneumonia_NN is_VBZ high_JJ ._SENT However_RB ,_, symptoms_NNS suggesting_VBG pneumonia_NN may_MD be_VB muted_VBN in_IN debilitated_VBN or_CC elderly_JJ patients_NNS ,_, and_CC a_DT variety_NN of_IN other_JJ noninfectious_JJ conditions_NNS may_MD mimic_VB pneumonia_NN ._SENT Clinical_JJ findings_NNS alone_RB ,_, then_RB ,_, are_VBP not_RB sufficient_JJ for_IN a_DT definitive_JJ diagnosis_NN ._SENT A_DT variety_NN of_IN noninvasive_JJ and_CC invasive_JJ tests_NNS have_VBP been_VBN proposed_VBN as_IN guides_NNS for_IN diagnosis_NN and_CC treatment_NN of_IN hospital-acquired_JJ pneumonia_NN ._SENT The_DT American_NP College_NP of_IN Chest_NP Physicians_NPS convened_VBD a_DT panel_NN of_IN experts_NNS to_TO establish_VB diagnostic_JJ recommendations_NNS for_IN ventilator-associated_JJ pneumonia_NN based_VBN upon_IN an_DT evidence-based_JJ assessment_NN of_IN the_DT medical_JJ literature_NN ._SENT The_DT executive_JJ summary_NN prepared_VBN by_IN that_DT committee_NN concluded_VBD that_IN the_DT lack_NN of_IN specificity_NN of_IN clinical_JJ findings_NNS and_CC the_DT poor_JJ reproducibility_NN of_IN chest_NN radiography_NN warrant_VBP the_DT performance_NN of_IN additional_JJ procedures_NNS ,_, such_JJ as_IN cultures_NNS of_IN specimens_NNS from_IN the_DT lower_JJR respiratory_JJ tract_NN ._SENT Although_IN qualitative_JJ culture_NN and_CC Gram_NP stain_NN of_IN endotracheal_JJ sputum_NN samples_NNS are_VBP the_DT least_JJS invasive_JJ tests_NNS ,_, they_PP have_VBP the_DT same_JJ pitfalls_NNS for_IN hospitalized_VBN patients_NNS as_IN for_IN patients_NNS in_IN the_DT community_NN ,_, that_WDT is_VBZ ,_, poor_JJ predictive_JJ values_NNS ._SENT Both_DT pathogens_NNS and_CC nonpathogens_NNS alike_RB may_MD be_VB recovered_VBN ._SENT Bronchoscopy_NN has_VBZ been_VBN advocated_VBN by_IN many_JJ ._SENT Samples_NNS that_WDT can_MD be_VB obtained_VBN by_IN bronchoscopy_NN include_VBP bronchial_JJ brushings_NNS ,_, bronchial_JJ washings_NNS ,_, bronchoalveolar_JJ lavage_NN (_( BAL_NP )_) fluid_NN ,_, and_CC transbronchial_JJ biopsy_NN specimens_NNS ._SENT It_PP is_VBZ important_JJ that_IN a_DT standardized_JJ approach_NN be_VB followed_VBN ._SENT Baselski_NP and_CC Wunderink_NP describe_VBP in_IN detail_NN appropriate_JJ collection_NN and_CC handling_NN techniques_NNS ._SENT Two_CD diagnostic_JJ approaches_NNS are_VBP described_VBN :_: the_DT serial_JJ dilution_NN method_NN ,_, in_IN which_WDT two_CD 100-fold_NN dilutions_NNS are_VBP made_VBN ,_, followed_VBN by_IN plating_VBG of_IN a_DT measured_VBN 0.1-ml_NN amount_NN of_IN material_NN on_IN an_DT agar_NN medium_NN ,_, with_IN direct_JJ colony_NN counts_NNS reported_VBD as_IN the_DT number_NN of_IN CFU_NP per_IN milliliter_NN ,_, and_CC the_DT calibrated_VBN loop_NN method_NN ,_, which_WDT is_VBZ similar_JJ to_TO the_DT method_NN used_VBN for_IN the_DT plating_NN of_IN urine_NN samples_NNS ._SENT Established_JJ quantities_NNS for_IN contamination_NN versus_CC infection_NN are_VBP >103_JJ CFU_NP of_IN a_DT single_JJ organism_NN per_IN ml_NN for_IN protected_VBN specimen_NN brushes_NNS (_( PSBs_NP )_) and_CC >104_NP CFU_NP of_IN a_DT single_JJ organism_NN per_IN ml_NN for_IN BAL_JJ fluid_NN ._SENT The_DT PSB_NP technique_NN involves_VBZ advancing_VBG a_DT double-catheter_NN brush_NN that_WDT contains_VBZ a_DT distal_JJ occluding_VBG plug_NN through_IN a_DT fiberoptic_JJ bronchoscope_NN ._SENT After_IN the_DT bronchoscope_NN is_VBZ wedged_VBN ,_, the_DT plug_NN is_VBZ ejected_VBN and_CC distal_JJ secretions_NNS are_VBP sampled_VBN via_IN the_DT brush_NN ._SENT The_DT brush_NN is_VBZ then_RB retracted_VBN through_IN the_DT inner_JJ lumen_NN of_IN the_DT catheter_NN ,_, which_WDT in_IN turn_NN is_VBZ retracted_VBN into_IN the_DT outer_JJ cannula_NN ._SENT A_DT limitation_NN of_IN this_DT procedure_NN is_VBZ the_DT small_JJ volume_NN obtained_VBN (_( similar0.001_JJ ml_NN )_) ,_, which_WDT is_VBZ diluted_VBN in_IN 1_CD ml_NN of_IN transport_NN medium_NN ._SENT A_DT criticism_NN of_IN the_DT literature_NN advocating_VBG the_DT PSB_NP technique_NN is_VBZ that_IN the_DT quality_NN of_IN the_DT samples_NNS is_VBZ usually_RB not_RB reported_VBN ._SENT Mertens_NP et_FW al._FW suggest_VBP that_IN samples_NNS obtained_VBN by_IN the_DT PSB_NN technique_NN be_VB screened_VBN by_IN using_VBG cytospin_JJ Gram_NP stains_NNS ._SENT Specimens_NNS containing_VBG <10_JJ cells_NNS per_IN high-power_NN field_NN may_MD reflect_VB poor_JJ sampling_NN ,_, indicating_VBG unreliable_JJ results_NNS ._SENT Many_JJ intensive_JJ care_NN specialists_NNS prefer_VBP BAL_JJ fluid_NN because_IN a_DT large_JJ number_NN of_IN alveoli_NNS (_( similar106_NN )_) are_VBP sampled_VBN ._SENT Reported_JJ sensitivities_NNS of_IN quantitative_JJ BAL_JJ fluid_NN cultures_NNS range_VBP from_IN 42_CD to_TO 93_CD %_NN ,_, with_IN a_DT mean_NN of_IN 73_CD %_NN ,_, and_CC specificities_NNS range_VBP from_IN 45_CD to_TO 100_CD %_NN ,_, with_IN a_DT mean_NN of_IN 82_CD %_NN ._SENT The_DT specificity_NN is_VBZ higher_JJR (_( 89_CD to_TO 100_CD %_NN )_) when_WRB intracellular_JJ organisms_NNS are_VBP detected_VBN ._SENT Results_NNS vary_VBP due_JJ to_TO differences_NNS in_IN the_DT population_NN studied_VBD ,_, the_DT prior_JJ administration_NN of_IN antibiotics_NNS ,_, and_CC the_DT reference_NN test_NN compared_VBN ._SENT Finally_RB ,_, blinded_VBD invasive_JJ procedures_NNS have_VBP been_VBN advocated_VBN by_IN some_DT because_IN of_IN the_DT expense_NN and_CC potential_JJ risk_NN of_IN invasive_JJ procedures_NNS ._SENT Some_DT of_IN these_DT methods_NNS include_VBP mini-BAL_NN ,_, blinded_VBD bronchial_JJ sampling_NN ,_, and_CC blinded_VBD sampling_VBG by_IN the_DT PSB_NP technique_NN ._SENT The_DT reported_VBN sensitivities_NNS and_CC specificities_NNS are_VBP similar_JJ to_TO those_DT for_IN invasive_JJ techniques_NNS ._SENT Since_IN the_DT involved_VBN portion_NN of_IN the_DT lung_NN may_MD be_VB missed_VBN ,_, this_DT technique_NN should_MD probably_RB be_VB reserved_VBN for_IN patients_NNS too_RB unstable_JJ to_TO undergo_VB bronchoscopy_NN ._SENT Regardless_RB of_IN the_DT quantitative_JJ method_NN used_VBN ,_, the_DT American_NP College_NP of_IN Chest_NP Physicians_NPS '_POS position_NN is_VBZ that_IN there_EX are_VBP insufficient_JJ outcomes_NNS data_NNS to_TO show_VB that_DT treatment_NN based_VBN on_IN the_DT results_NNS of_IN quantitative_JJ testing_NN ensures_VBZ a_DT better_RBR clinical_JJ outcome_NN ._SENT In_IN contrast_NN ,_, a_DT large_JJ randomized_VBN trial_NN among_IN 31_CD intensive_JJ care_NN units_NNS in_IN France_NP showed_VBD that_IN a_DT management_NN strategy_NN involving_VBG invasive_JJ procedures_NNS was_VBD significantly_RB associated_VBN with_IN reduced_VBN rates_NNS of_IN mortality_NN and_CC morbidity_NN and_CC resulted_VBD in_IN less_JJR antibiotic_JJ use_NN ._SENT Perhaps_RB the_DT greatest_JJS utility_NN of_IN quantitative_JJ cultures_NNS of_IN specimens_NNS obtained_VBN by_IN invasive_JJ procedures_NNS at_IN present_NN may_MD be_VB in_IN reducing_VBG antibiotic_JJ use_NN for_IN clinically_RB insignificant_JJ organisms_NNS and_CC for_IN distinguishing_VBG between_IN pneumonia_NN and_CC adult_JJ respiratory_JJ distress_NN syndrome_NN or_CC other_JJ noninfectious_JJ causes_NNS ._SENT Also_RB ,_, there_EX is_VBZ general_JJ agreement_NN at_IN this_DT time_NN that_IN the_DT usefulness_NN of_IN repeated_JJ quantitative_JJ cultures_NNS to_TO assess_VB the_DT response_NN to_TO therapy_NN needs_VBZ to_TO be_VB better_RBR studied_VBN ._SENT Pneumonia_NN is_VBZ one_CD of_IN the_DT most_RBS life-threatening_JJ infections_NNS in_IN the_DT immunocompromised_JJ host_NN ._SENT A_DT broad_JJ range_NN of_IN pathogens_NNS needs_VBZ to_TO be_VB excluded_VBN ;_: and_CC the_DT infectious_JJ agents_NNS to_TO be_VB considered_VBN vary_VBP depending_VBG upon_IN the_DT type_NN and_CC duration_NN of_IN immunosuppression_NN ,_, past_JJ exposures_NNS ,_, geographic_JJ location_NN ,_, and_CC the_DT nature_NN of_IN the_DT treatments_NNS administered_VBN ._SENT Less_RBR controversial_JJ than_IN the_DT diagnostic_JJ utility_NN of_IN ventilator-associated_JJ pneumonia_NN is_VBZ perhaps_RB the_DT diagnostic_JJ utility_NN of_IN fiberoptic_JJ bronchoscpy_NN in_IN this_DT setting_NN ._SENT BAL_NN protocols_NNS which_WDT process_VBP samples_NNS for_IN both_DT viral_JJ and_CC bacterial_JJ pathogens_NNS ,_, Pneumocystis_NP ,_, Legionella_NP ,_, fungi_NNS ,_, and_CC mycobacteria_NNS as_RB well_RB as_IN cytologic_JJ analysis_NN for_IN noninfectious_JJ causes_NNS may_MD be_VB appropriate_JJ ._SENT Such_JJ protocols_NNS require_VBP communication_NN between_IN the_DT clinical_JJ microbiology_NN laboratory_NN ,_, infectious_JJ diseases_NNS specialists_NNS ,_, pulmonologists_NNS ,_, and_CC transplant_NN teams_NNS ._SENT In_IN summary_NN ,_, lower_JJR respiratory_JJ tract_NN infections_NNS are_VBP among_IN the_DT most_RBS commonly_RB encountered_VBN infectious_JJ diseases_NNS causing_VBG significant_JJ morbidity_NN and_CC mortality_NN ._SENT The_DT role_NN of_IN the_DT microbiology_NN laboratory_NN in_IN diagnosis_NN remains_VBZ controversial_JJ until_IN better_JJR standardization_NN of_IN methods_NNS and_CC outcomes_NNS data_NNS are_VBP generated_VBN ._SENT Empirical_JJ treatment_NN approaches_NNS are_VBP recommended_VBN for_IN bronchitis_NN and_CC CAP_NN not_RB requiring_VBG hospitalization_NN ._SENT In_IN the_DT hospitalized_VBN patient_NN ,_, although_IN diagnostic_JJ tests_NNS are_VBP imperfect_JJ ,_, they_PP are_VBP suggested_VBN ._SENT This_DT is_VBZ particularly_RB true_JJ for_IN the_DT immunocompromised_JJ host_NN ,_, for_IN whom_WP invasive_JJ procedures_NNS guided_VBN by_IN clinical_JJ and_CC epidemiological_JJ data_NNS may_MD reveal_VB unsuspected_JJ opportunistic_JJ pathogens_NNS ._SENT 